81 related articles for article (PubMed ID: 6830632)
1. Dansylarginine N-(3-ethyl-1.5-pentanediyl)amide. A potent and selective fluorescent inhibitor of butyrylcholinesterase.
Brimijoin S; Mintz KP; Prendergast FG
Biochem Pharmacol; 1983 Feb; 32(4):699-706. PubMed ID: 6830632
[TBL] [Abstract][Full Text] [Related]
2. Progressive development of a thrombin inhibitor binding site.
Hibbard LS; Nesheim ME; Mann KG
Biochemistry; 1982 May; 21(10):2285-92. PubMed ID: 6896460
[TBL] [Abstract][Full Text] [Related]
3. Isolation and autolysis of human meizothrombin in the presence of dansylarginine-N-(3-ethyl-1,5-pentanediyl)amide.
Pei G; Lentz BR
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):309-16. PubMed ID: 1893062
[TBL] [Abstract][Full Text] [Related]
4. N alpha-dansyl-L-arginine 4-phenylpiperidine amide. A potent and selective inhibitor of horse serum cholinesterase.
Hijikata-Okunomiya A; Okamoto S; Tamao Y; Kikumoto R
J Biol Chem; 1988 Aug; 263(23):11269-73. PubMed ID: 3403526
[TBL] [Abstract][Full Text] [Related]
5. Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.
Nesheim ME; Prendergast FG; Mann KG
Biochemistry; 1979 Mar; 18(6):996-1003. PubMed ID: 427102
[No Abstract] [Full Text] [Related]
6. Effects of dansyl-arginyl-(4'-ethyl)piperidine amide on gonadotropin binding to rat tissues.
McIlroy PJ; Bergert ER; Ryan RJ
Endocrinology; 1983 Jul; 113(1):222-7. PubMed ID: 6861698
[TBL] [Abstract][Full Text] [Related]
7. Horse serum butyrylcholinesterase kinetics: a molecular mechanism based on inhibition studies with dansylaminoethyltrimethylammonium.
Cauet G; Friboulet A; Thomas D
Biochem Cell Biol; 1987 Jun; 65(6):529-35. PubMed ID: 3426832
[TBL] [Abstract][Full Text] [Related]
8. [Effect of carbodiimides on the catalytic properties of cholinesterases].
Volkova RI; Kochetova LM
Biokhimiia; 1981 Oct; 46(10):1823-31. PubMed ID: 6946838
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gonadotropin-stimulated adenylate cyclase by dansyl-arginyl-(4'-ethyl)piperidine amide (DAPA).
Wilks JW; Campbell JA; Hui OJ
Biol Reprod; 1986 Nov; 35(4):877-80. PubMed ID: 3101759
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.
Pearlstein E; Ambrogio C; Gasic G; Karpatkin S
Cancer Res; 1981 Nov; 41(11 Pt 1):4535-9. PubMed ID: 7306974
[TBL] [Abstract][Full Text] [Related]
11. Active-site-directed fluorescent probes in the kinetics and spectroscopy of purified horse serum cholinesterase.
Chan LM; Himel CM; Main AR
Biochemistry; 1974 Jan; 13(1):86-90. PubMed ID: 4808706
[No Abstract] [Full Text] [Related]
12. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.
Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ
Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888
[TBL] [Abstract][Full Text] [Related]
13. Aprophen: a substrate and inhibitor of butyrylcholinesterase and carboxylesterases.
Rush RS; Ralston JS; Wolfe AD
Biochem Pharmacol; 1985 Jun; 34(12):2063-8. PubMed ID: 4004924
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the butyrylcholinesterase by ethidium bromide.
Patocka J
Biomed Biochim Acta; 1987; 46(11):769-74. PubMed ID: 3446203
[TBL] [Abstract][Full Text] [Related]
15. Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
Berman HA; Leonard K
Mol Pharmacol; 1992 Feb; 41(2):412-8. PubMed ID: 1538717
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide.
Pearlstein E; Ambrogio C; Gasic G; Karpatkin S
Prog Clin Biol Res; 1982; 89():479-502. PubMed ID: 6287488
[No Abstract] [Full Text] [Related]
17. [Kinetics of reversible inhibition of cholinesterases by quaternary diaminoalkyl esters of aromatic dicarboxylic acids].
Volkova RI; Dmitrieva EN
Biokhimiia; 1976 Mar; 41(3):443-51. PubMed ID: 1276277
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine.
Kamal MA; Al-Jafari AA; Yu QS; Greig NH
Biochim Biophys Acta; 2006 Feb; 1760(2):200-6. PubMed ID: 16309845
[TBL] [Abstract][Full Text] [Related]
19. Optical spectroscopy of nicotinoprotein alcohol dehydrogenase from Amycolatopsis methanolica: a comparison with horse liver alcohol dehydrogenase and UDP-galactose epimerase.
Piersma SR; Visser AJ; de Vries S; Duine JA
Biochemistry; 1998 Mar; 37(9):3068-77. PubMed ID: 9485460
[TBL] [Abstract][Full Text] [Related]
20. Highly selective inhibition of butyrylcholinesterase by a novel melatonin-tacrine heterodimers.
Zawadzka A; Lozińska I; Molęda Z; Panasiewicz M; Czarnocki Z
J Pineal Res; 2013 May; 54(4):435-41. PubMed ID: 24325732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
